Sunrise to Launch Home Sleep Tests in US
Belgium-based Sunrise plans to launch its chin patch home sleep test in the US after receiving US Food and Drug Administration clearance for its second-generation device late last year and closing a €17 million ($18.2 million) funding round. Laurent Martinot, CEO and co-founder of the company, says the new device, which uses a mandibular jaw…